TRIM14
TRIM14 (tripartite motif containing 14, also known as KIAA0129) is a member of the TRIM/RBCC family that contributes to innate immune defence against viruses and bacteria. It acts as a signalling adaptor in type I interferon and NF-kappa-B pathways. Browse Assay Genie's current range of TRIM14 research reagents below, or read on for the biology behind the target.
TRIM14 plays an essential role in the innate immune defence against viruses and bacteria. At the outer mitochondrial membrane it interacts with MAVS and recruits the NF-kappa-B essential modulator IKBKG/NEMO to the MAVS signalosome, activating both the IRF3 and NF-kappa-B pathways and facilitating the type I interferon response. It also positively regulates CGAS-induced type I interferon signalling by stabilising CGAS and inhibiting its autophagic degradation, and it acts as a scaffold between TBK1 and STAT3 to promote STAT3 phosphorylation and resolve interferon-stimulated gene expression.
The protein also acts against specific viruses. It promotes Lys-48-linked ubiquitination and subsequent degradation of hepatitis C virus NS5A, which inhibits viral replication. It contributes to the inhibition of ebolavirus infection by enhancing IFN-beta and NF-kappa-B activation after binding the viral protein NP. Beyond antiviral signalling, TRIM14 inhibits the transcriptional activity of SPI1 in a dose-dependent manner. It also inhibits OPTN-mediated selective autophagic degradation of KDM4D by recruiting USP14, which removes Lys-63-linked ubiquitination from KDM4D, and so negatively regulates H3K9me2 and H3K9me3.
The TRIM14 gene encodes a member of the tripartite motif family, whose motif comprises a RING, a B-box type 1 and a B-box type 2 zinc-binding domain, plus a coiled-coil region. UniProt lists localisation to the mitochondrion outer membrane, phagosome and nucleus, while the NCBI summary notes cytoplasmic bodies. Alternative splicing gives multiple transcript variants. The mouse ortholog is Trim14, and KIAA0129 is a former designation for the human gene.
TRIM14 promotes degradation of hepatitis C virus NS5A and enhances IFN-beta and NF-kappa-B activation in response to the ebolavirus protein NP.
It links MAVS to IKBKG/NEMO, activating IRF3 and NF-kappa-B, and stabilises CGAS to support CGAS-induced interferon signalling.
TRIM14 inhibits autophagic degradation of CGAS and, through USP14, protects KDM4D from OPTN-mediated degradation.
By stabilising KDM4D it negatively regulates H3K9me2 and H3K9me3, and it also inhibits the transcriptional activity of SPI1.
TRIM14 supports innate immune defence against viruses and bacteria. It recruits IKBKG/NEMO to the MAVS signalosome to activate IRF3 and NF-kappa-B, stabilises CGAS, and scaffolds TBK1 and STAT3. It also promotes degradation of hepatitis C virus NS5A.
Yes. KIAA0129 is a previous symbol, and the earlier name was tripartite motif-containing 14. The protein belongs to the TRIM/RBCC family. Alternative splicing of the TRIM14 gene produces multiple transcript variants, as noted in the NCBI Gene summary.
A mouse ortholog, Trim14, is recorded for the human gene. The source data give no rat ortholog. Researchers working in other species should confirm cross-reactivity, and check the datasheet of any product for its validated reactivity.
Other TRIM family proteins involved in immune signalling, ubiquitination and transcriptional regulation.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q14142; product specifications from Assay Genie datasheets.